Reimbursement Briefs: PillCam Reimbursement In Japan; 3-D Mammo Code Withdrawn; CMS Data Sharing
This article was originally published in The Gray Sheet
Japan will reimburse PillCam COLON. 3-D mammography CPT code application withdrawn from AMA CPT Editorial Panel meeting. CMS unveils new virtual research data-sharing tool.
You may also be interested in...
The Senate approved Sylvia Mathews Burwell as HHS Secretary on a bipartisan vote. The new secretary recently responded to questions on policy issues from the Senate Finance Committee, including on the pending Sunshine Act payment disclosure database and on imaging reimbursement matters.
The $860 million purchase agreement will give Covidien the dominant capsule endoscopy platform on the market as the company hopes for FDA approval this year of PillCam COLON 2 as a less invasive alternative for patients who are unable to undergo a colonoscopy.
Firm initially will pursue diagnostic imaging claim for its PillCam Colon 2 video capsule, rather than a screening claim, as the fastest route to U.S. market. The strategy shift follows preliminary clinical trial data review.